Pharmaceutical preparations for the treatment of COVID 19, coronaviruses, and respiratory and infectious diseases; Pharmaceuticals, namely, prodrugs, protein fusion compounds and inhibitors for the treatment of COVID-19, coronaviruses, and respiratory and infectious diseases; Antiviral prodrugs